Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00024505 · ClinicalTrials.gov registry record
Multidisciplinary Study of Right Ventricular Dysplasia
A clinical trial of Heart Diseases and Arrhythmogenic Right Ventricular Dysplasia, sponsored by University of Arizona.
- Completed
- Registry status
- 320
- Enrollment target
- 1
- Study location
NCT00024505 is a study of Heart Diseases and Arrhythmogenic Right Ventricular Dysplasia that has completed, run by University of Arizona. The registered enrollment target is 320 participants, below the 5,528-participant average among 85 other Heart Diseases trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00024505, a study of Heart Diseases and Arrhythmogenic Right Ventricular Dysplasia, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 320 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the cardiac, clinical, and genetic aspects of arrhythmogenic right ventricular dysplasia (ARVD), a progressive disorder that predominantly affects the right side of the heart and causes ventricular arrhythmias.
Conditions Studied
Study Locations (1)
Arizona
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2001-09 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00024505
The ClinicalTrials.gov registry entry for NCT00024505 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,528-participant average among 85 other Heart Diseases trials with a reported enrollment target (94% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT00024505 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT00024505 about?
NCT00024505 is a clinical study titled "Multidisciplinary Study of Right Ventricular Dysplasia". The purpose of this study is to investigate the cardiac, clinical, and genetic aspects of arrhythmogenic right ventricular dysplasia (ARVD), a progressive disorder that predominantly affects the right side of the heart and causes ventricular arrhythmias.
What is the current status of trial NCT00024505?
This trial is currently completed. The enrollment target is 320 participants. The study started on 2001-09. Estimated completion is 2010-07.
What conditions does trial NCT00024505 study?
This clinical trial studies the following conditions: Heart Diseases, Arrhythmogenic Right Ventricular Dysplasia.
Who is sponsoring clinical trial NCT00024505?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00024505 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Lumason® Infusion vs. Bolus Administrations
RECRUITING · Phase 3
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.